C12N 2760/20061
Methods of inactivation or attenuation
C12N2760/20061 (Methods of inactivation or attenuation) appears on 6 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 13
- Assignees
- 8
- Inventors
- 23
- Latest grant
- 7 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Non-replicating virus-derived particles and uses thereof7 Sep 2021US 11,110,138 B2Celverum Inc.
- Attenuated virus having multiple hosts3 Sep 2019US 10,400,220 B2The Research Foundation for The State University of New York
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Oncolytic rhabdovirus20 Feb 2018US 9,896,664 B2Turnstone Limited Partnership
- Methods for viral inactivation and other adventitious agents15 Nov 2016US 9,493,744 B2Genentech, Inc.
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma24 Oct 2024US 2024/0350691 A1Aphios Corporation
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents25 May 2023US 2023/0159886 A1Genentech, Inc.
- Virus-free cell cultures9 Mar 2023US 2023/0075854 A1Biomarin Pharmaceutical Inc.
Most cited
By later US patents